Articles with "response survival" as a keyword



Photo from wikipedia

Evaluation of correlation between CD44, radiotherapy response, and survival rate in patients with advanced stage of head and neck squamous cell carcinoma (HNSCC)

Sign Up to like & get
recommendations!
Published in 2022 at "Cancer Medicine"

DOI: 10.1002/cam4.4497

Abstract: Cancer stem cells (CSCs) constitute a distinctive subpopulation of cancer cells that are competent in tumor initiation, invasion, recurrence, and resistance to chemoradiotherapy. CD44, a hyaluronic acid (HA) receptor has been considered as a potential… read more here.

Keywords: cd44; head neck; response survival; correlation cd44 ... See more keywords
Photo from wikipedia

Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study

Sign Up to like & get
recommendations!
Published in 2018 at "Annals of Hematology"

DOI: 10.1007/s00277-018-3416-4

Abstract: In a prospective randomized study, treatment for aplastic anemia (AA) with rabbit antithymocyte globulin (r-ATG) and cyclosporine showed inferior hematological response and survival in comparison to horse antithymocyte globulin (h-ATG) and cyclosporine. However, h-ATG was… read more here.

Keywords: response; atg; response survival; antithymocyte globulin ... See more keywords
Photo by emben from unsplash

Tree dynamic response and survival in a category-5 tropical cyclone: The case of super typhoon Trami

Sign Up to like & get
recommendations!
Published in 2022 at "Science Advances"

DOI: 10.1126/sciadv.abm7891

Abstract: In the future with climate change, we expect more forest and tree damage due to the increasing strength and changing trajectories of tropical cyclones (TCs). However, to date, we have limited information to estimate likely… read more here.

Keywords: survival category; tree dynamic; dynamic response; response survival ... See more keywords
Photo from wikipedia

A tumor vasculature–based imaging biomarker for predicting response and survival in patients with lung cancer treated with checkpoint inhibitors

Sign Up to like & get
recommendations!
Published in 2022 at "Science Advances"

DOI: 10.1126/sciadv.abq4609

Abstract: Tumor vasculature is a key component of the tumor microenvironment that can influence tumor behavior and therapeutic resistance. We present a new imaging biomarker, quantitative vessel tortuosity (QVT), and evaluate its association with response and… read more here.

Keywords: imaging biomarker; response; tumor vasculature; response survival ... See more keywords
Photo from wikipedia

Abstract 6669: Antigen features are associated with response and survival after neoadjuvant chemo-immunotherapy for muscle-invasive bladder cancer

Sign Up to like & get
recommendations!
Published in 2023 at "Cancer Research"

DOI: 10.1158/1538-7445.am2023-6669

Abstract: In the Phase II LCCC1520 trial, neoadjuvant chemo-immunotherapy (pembrolizumab with gemcitabine plus cisplatin) induced response in 22 of 39 muscle-invasive bladder cancer patients[1]. In this correlative analysis, we identify molecular features associated with response and… read more here.

Keywords: antigen; survival; response survival; associated response ... See more keywords
Photo by nci from unsplash

Association between complete response and survival in advanced melanoma treated with talimogene laherparepvec (T-VEC) plus ipilimumab (ipi).

Sign Up to like & get
recommendations!
Published in 2020 at "Journal of Clinical Oncology"

DOI: 10.1200/jco.2020.38.15_suppl.10029

Abstract: 10029Background: This is the first randomized trial testing the addition of an oncolytic virus to an immune checkpoint inhibitor for advanced melanoma. At the 3-year (yr) follow-up, the combination... read more here.

Keywords: advanced melanoma; association complete; response survival; survival advanced ... See more keywords
Photo by mightyhummingbird from unsplash

Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors

Sign Up to like & get
recommendations!
Published in 2023 at "Cancers"

DOI: 10.3390/cancers15071968

Abstract: Simple Summary Accurate and early selection of patients with advanced non-small-cell lung cancer (NSCLC) who would benefit from immunotherapy is of the utmost clinical importance. The aim of our retrospective multi-centric study was to determine… read more here.

Keywords: treated immune; delta radiomics; response survival; response ... See more keywords